BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Prosonix 

The Magdalen Centre
Robert Robinson Avenue
Oxford Science Park  Oxford   OX4 4GA   United Kingdom
Phone: 44-0-1865-784250 Fax: 44-0-1865-784251


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Prosonix To Present Results Of Phase 2 Clinical Study Of PSX1002 In Chronic Obstructive Pulmonary Disease (COPD) At The American Thoracic Society Meeting 5/15/2014 7:32:12 AM
Prosonix Reports Positive Top-Line Results From Its Phase 2 Clinical Study With PSX1002 In Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) 1/23/2014 8:24:15 AM
Final Patient Completes Prosonix' Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 8/16/2013 10:18:18 AM
Prosonix Appoints Frank Condella as Non-executive Director 7/1/2013 6:32:40 AM
Prosonix Initiates Phase 2 Clinical Study With PSX1002 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 5/22/2013 9:49:06 AM
Prosonix Sets Date for First Quarter Fiscal Year 2013 Earnings Release: August 2, 2012 7/5/2012 10:49:55 AM
Prosonix Enters Collaboration With Imperial College London to Accelerate Development of Engineered Combination Respiratory Medicines (Multi-component Particles™, MCPs™) 7/5/2012 10:47:41 AM